ADVANCED OVARIAN CARCINOMA
Clinical trials for ADVANCED OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase trial tests a new drug (BAY 1895344) combined with standard chemotherapy in people with advanced solid tumors, especially bladder cancer. The goal is to find the safest dose and see how well the combination works. About 74 adults with cancers like lung, bladder, …
Matched conditions: ADVANCED OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: ADVANCED OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Ovarian cancer drug study aims to unlock DNA secrets before surgery
Knowledge-focused OngoingThis early-phase study is testing a drug called adavosertib in women with advanced ovarian, fallopian tube, or peritoneal cancer before they have surgery to remove tumors. The goal is to see how the drug changes the DNA of cancer cells, which may help doctors plan more effective …
Matched conditions: ADVANCED OVARIAN CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC